KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Return on Capital Employed (2016 - 2025)

Resmed's Return on Capital Employed history spans 16 years, with the latest figure at 0.25% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 1.0% year-over-year to 0.25%; the TTM value through Dec 2025 reached 0.25%, up 1.0%, while the annual FY2025 figure was 0.26%, 4.0% up from the prior year.
  • Return on Capital Employed reached 0.25% in Q4 2025 per RMD's latest filing, up from 0.25% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.25% in Q4 2025 to a low of 0.19% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 0.23%, with a median of 0.23% recorded in 2021.
  • Peak YoY movement for Return on Capital Employed: rose 18bps in 2021, then dropped -5bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.24% in 2021, then dropped by -15bps to 0.2% in 2022, then decreased by -7bps to 0.19% in 2023, then soared by 31bps to 0.25% in 2024, then increased by 3bps to 0.25% in 2025.
  • Per Business Quant, the three most recent readings for RMD's Return on Capital Employed are 0.25% (Q4 2025), 0.25% (Q3 2025), and 0.25% (Q2 2025).